Letter to the Editor

Wilson WA , Gharavi AE , Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop . Arthritis Rheum 1999; 49: 1309-1311 .

Khamashta MA , Guadrado MJ , Mujic F , Taub NA , Hunt BJ , Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome . N Engl J Med 1995; 332: 993-997 .

Flageul B , Wallach D , Cavelier-Balloy B , Bachelez H , Carsuzaa F , Dubertret L. Thalidomide and thrombosis . Ann Dermatol Venereol 2000; 127: 171-174 .

Pouaha J , Martin S , Trechot P et al. Thalidomide and thrombosis: Three observations . Presse Med 2001; 30: 1008-1009 .

Esteve E , Legac E. Thrombose veineuse et embolie pulmonoraire au cours d’une aphtosetraitèe par thalidomide . Ann Intern Med 1998;128: 443-450 .

Osman K , Comenzo R , Rajkumar SV. Deep venous thrombosis and thalidomide therapy for multiple myeloma . N Engl J Med 2001; 344: 1951-1952 .

Zangari M , Anaissie E , Barlogie B et al. Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy . Blood 2001; 98: 1614-1615 .

Escudier B , Lassau N , Leborgne S et al. Thalidomide and venous thrombosis . Ann Intern Med 2002; 13: 711-711 .

Petter C. Early foetal thrombosis induced by thalidomide in mouse: possible explanation for teratogenicity . Experientia 1977; 33: 1384-1386 .

Piette JC , Sbaï A , Francès C. Warning: thalidomide-related thrombotic risk potentially concerns patients with lupus . Lupus 2002; 11: 67-70 .